Answers are grounded in this paper and cite their sources.
Background: Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer deaths worldwide, with both incidence and mortality projected to increase by 2040. Current screening programs, based on the Fecal Immunochemical Test (FIT) and colonoscopy, carry low sensitivity for advanced adenomas, invasiveness, and suboptimal patient adherence. Exhaled breath analysis represents a new promising non-invasive alternative solution, through the detection of the characteristic profile of Volatile Organic Compounds (VOCs) using an electronic nose. Methods: This exploratory case–control study (CEAVC ID 16770_bio) enrolled subjects over 50 years of age: patients with CRC, pre-neoplastic lesions and with No Alteration (NA). Exhaled breath samples were collected for each participant via three forced exhalations. A two-class classification model was developed for the electronic nose analysis, categorizing results as either positive (CRC/high-risk lesions) or negative (NA/intermediate/low-risk lesions). Results and Conclusions: Based on the analysis of 124 samples, the developed method achieved a sensitivity of 0.83 (CRC and high-risk lesions) and a specificity of 0.74, and an area under the ROC curve of 0.82. This work explores the potential for further development of a method, based on the analysis of exhaled breath using an e-nose, that could be fast, potentially low-cost, non-invasive, and which, by its very nature, could improve population adherence to CRC screening programs.
No takes yet. Share an insight, caveat, or question.
Rapi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: